LATEST ARTICLES

Major health insurer Cigna is mulling a sale of its group benefits business in a deal that could be valued at up...
Balancing safety while also supporting innovation to help patients access new therapies means that the pendulum at the Food and Drug Administration...
This squat challenge will make you fitter, stronger, and sporting the best butt of your life! Are you ready to get your...
The health plan hopes to better address the needs of underserved populations through community-based teams that can understand and overcome social barriers...
The Food and Drug Administration’s rejection Monday of Sarepta Therapeutics’ second drug for Duchenne muscular dystrophy came as a surprise to many....